Renal Pharmaceuticals

Specializing in the prescription needs of the ESRD patient

Fresenius Renal Pharmaceuticals is dedicated to providing pharmaceuticals services to the more than 400,000 individuals undergoing dialysis throughout the United States.

Dietitian with patient reviewing prescription

Take a closer look at our offerings:

Renal_Therapies_Group_logo

Iron Sucrose Injection for the ESRD patient >

Our Roots Run Deep. Visit our website to discover the Venofer difference.

Velphoro® – the first non-calcium iron-based chewable phosphate binder >

Discover how potency makes it possible at our website.

Calcium acetate oral solution for ESRD patients >

Visit our webite to see why Phoslyra is clearly different.

Indications & Important Safety Information

Venofer

Velphoro

Phoslyra

PhosLo

Interested in learning more about Fresenius Renal Pharmaceuticals?

View the Pharmaceutical Return Policy. Please check frequently because policies may change without notice. To view pdf files, you need to download Adobe Acrobat Reader™.

© 2015, 2017, Fresenius Medical Care, All Rights Reserved. Fresenius Medical Care, Fresenius Renal Pharmaceuticals, the triangle logo, PhosLo, and Phoslyra are trademarks of Fresenius Medical Care Holdings, Inc and/or its affiliated companies. All other trademarks are the property of their respective owners.  Phoslyra® is manufactured for Fresenius Medical Care North America. PhosLo® is manufactured for Fresenius Medical Care North America. Venofer® is manufactured under license from Vifor (International) Inc., Switzerland and American Regent, Inc. Shirley, NY. Velphoro® is made in Switzerland and distributed by Fresenius Medical Care North America.  P/N 102763-02 Rev B 06/2017